Loading...

MD: Share Repurchase Plan And Margin Gains Will Support Future Performance

Published
28 May 25
Updated
05 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
33.3%
7D
20.0%

Author's Valuation

US$19.927.6% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 05 Nov 25

Fair value Increased 19%

Analysts have raised their price target for Pediatrix Medical Group from $16.71 to $19.92, citing improvements in projected revenue growth and profit margins. What's in the News The Board of Directors of Pediatrix Medical Group authorized a buyback plan on August 18, 2025.